Superoxide dismutase and catalase anti-oxidant activity in leucocyte lysates from hypertensive patients: Effects of eprosartan treatment

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 1, 2009, Pages 24-30

  Labiós, Manuel ^a   Martínez, Marcial ^b   Gabriel, Francisco ^a   Guiral, Victoria ^a   Dasi, Francisco ^a   Beltrán, Belén ^b   Muñoz, Anna ^c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c Solvay Pharma   (Spain)

Author keywords

Catalase activity; Eprosartan; Hypertension; Superoxide dismutase

Indexed keywords

CATALASE; EPROSARTAN; HEMOGLOBIN; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL LYSATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOCYTE; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PILOT STUDY; SYSTOLIC BLOOD PRESSURE;

ACRYLATES; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; CATALASE; CELL EXTRACTS; FEMALE; HEART RATE; HUMANS; HYPERTENSION; IMIDAZOLES; LEUKOCYTES; MALE; MIDDLE AGED; SUPEROXIDE DISMUTASE; THIOPHENES;

EID: 67650492770     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309104067     Document Type: Article

References (30)

1. Labiós M., Martínez M., Gabriel F. et al. Effects of eprosartan on mitochondrial membrane potential and hydrogen peroxide production in leucocytes in hypertension. J Human Hypertens 2008;22:493-500.
2. Kumar KV, Das UN Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993;19:59-66.
3. Beyer W., Imlay J., Fridovich I. Superoxide dismutases. Prog Nucleic Acid Res Mol Biol 1991;40:221-53.
4. Crapo JD, Oury C., Rabouille C., Slot JW, Chang LY Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci U S A 1992;89:10405-09.
5. Stallings W. et al. The three-dimensional structure of iron superoxide dismutase: Kinetics and structural comparisons with Cu/Zn and Mn dismutases. In: Oxygen Radicals in Chemistry and Biology. Berlin: Walter de Gruyter & Co., 1984;779-92.
6. 2 release from intact peroxisomes. Biochem J 2002;363:483-91.
7. Goth L., Rass P., Pay A. Catalase enzyme mutations and their association with diseases. Mol Diagn 2004;8:141-9.
8. El Bekay R., Alvarez M., Monteseirin J. et al. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NK-&B. Blood 2003;102:662-71.
9. Bradford MM A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
10. Nebot C., Moutet H., Huet P., Xu JZ, Yadan JC, Chaudiere J. Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 1993;214:442-51.
11. Kidson CH Variations in catalase activity in human leucocytes. Blood 1962;19: 82-8.
12. Boyajian RA, Otis SM Atherogenic progression of carotid stenosis associates selectively with monocyte fraction in circulating leucocytes. Eur J Neurol 2002;9:307-10.
13. Mills PJ, Farag NH, Perez C., Dimsdale JE Peripheral blood mononuclear cell CD62L and CD11a expression and soluble interstitial cell adhesion molecule-1 levels following infused isoproterenol in hypertension. J Hypertens 2002;20:311-16.
14. Held C., Hjemdahl P., Hakan Wallen N. et al. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APIS study. The angina prognosis study in Stockholm. Atherosclerosis 2000;148:179-88.
15. Ruilope L., Jäger B., Prichard B. Eprosartan versus enalapril in elderly patients with hypertension: A double-blind, randomized trial. Blood Press 2001;10:223-9.
16. Hedner T. The clinical profile of the angiotensin II receptor blocker eprosartan. J Hypertens 2002;20 (suppl 5):S33-8.
17. Conter HS, McKay DW, Reiz RJ Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting. Can J Cardiol 2004;20(suppl C): 6C-10C.
18. Romero JC, Reckelhoff JF Role of angiotensin and oxidative stress in arterial hypertension. Hypertension 1999;34:943-9.
19. Wilcox CS Reactive oxygen species: Roles in blood pressure and kidney function. Curr Hypertens Rep 2002;4:160-6.
20. Vaziri ND, Liang K., Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 1999;56:1492-8.
21. Vaziri ND, Ni Z., Oveisi F., Trnavsky-Hobbs DL Effect of antioxidant therapy on blood pressure, and NO synthase expression in hypertensive rats. Hypertension 2000;36:957-64.
22. Makino A., Skelton MM, Zou AP, Roman RJ, Cowley AW Increased renal medullary stress produces hypertension. Hypertension 2002;39:667-72.
23. Touyz RM Reactive oxygen species in vascular biology: Role in arterial hypertension. Expert Rev Cardiovasc Ther 2003;1:91-106.
24. Yasunari K., Maeda K., Nakamura M., Yoshikawa J. Oxidative stress in leucocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 2002;39:377-80.
25. Yasunari K., Maeda K., Nakamura M., Yoshikawa J. Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress. Hypertension 2002;39:433-7.
26. Labiós M., Martínez M., Gabriel F., Guiral V., Muñoz A., Aznar J. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension. Am J Hypertens 2004;17:757-63.
27. Yasunari K., Maeda K., Nakamura M., Watanabe T., Yoshikawa J., Asada A. Effect of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. Am J Med 2005;118:201-02.
28. Yasunari K., Maeda K., Nakamura M., Watanabe T., Yoshikawa J. Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension. Hypertens Res 2005;28:107-12.
29. Khassaf M., McArdle A., Esanu C. et al. Effect of vitamin C supplements on antioxidant defence and stress proteins in human lymphocytes and skeletal muscle. J Physiol 2003;549:645-52.
30. Wilcox CS, Welch WJ Oxidative stress: Cause or consequence of hypertension. Exp Biol Med 2001;226:619-20.